关键数据
69.920今开
70.830最高
885.76K成交量
亏损市盈率 TTM
52.14市盈率动
--股息TTM
2.99%换手率
68.960昨收
64.880最低
48.57M成交额
亏损市盈率静
7.60市净率
0.00%股息率 TTM
-16.33%ROA
170.87052周最高
1.09量比
-52.29M净利润
29.67M总股本
-2.6604每股收益TTM
1.99Beta
-30.42%ROE
32.21052周最低
8.63%振幅
66.71%毛利率
1.93B总市值
0.03回报/风险
4.06%风险率
操作建议
GeneDx Holdings Corp当前公司基本面数据相对健康,增长潜力较大。当前估值合理,在医疗服务供应商行业排名11/75位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价92.89。中期看,股价处于上升通道。近一个月,市场表现较差,但基本面评分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。
压力支撑

由于公司未披露,未能获取相关数据
GeneDx Holdings Corp亮点
亮点风险
GeneDx Holdings Corp新闻
即将为您带来更多新闻,敬请期待。。。
收益预测
技术指标
财务指标
每股收益

由于公司未披露,未能获取相关数据
营业总收入

由于公司未披露,未能获取相关数据
GeneDx Holdings Corp简介
GeneDx Holdings Corp. is a genomics company. The Company operates, through its subsidiary, GeneDx, LLC, which is focused on exome and genome tests that translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. It operates through GeneDx segment, which primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing and, to a lesser extent, data and information services. Exome sequencing test options include XomeDx, XomeDx Plus, and XomeDxXpress. GeneDx genome sequencing evaluates the protein-coding and non-coding regions of an individual’s nuclear genome. GeneDx genome sequencing test options include GenomeSeqDx and GenomeXpress. It offers a menu of targeted variant testing options to meet the needs of families and healthcare providers. Its subsidiary, Fabric Genomics, Inc., specializes in artificial intelligence-powered genomic interpretation.
公司代码WGS
公司GeneDx Holdings Corp
CEOStueland (Katherine A)
网址https://sema4.com/
公司股东
常见问题
GeneDx Holdings Corp(WGS)的当前股价是多少?
GeneDx Holdings Corp(WGS)的当前股价是 65.11。
GeneDx Holdings Corp的股票代码是什么?
GeneDx Holdings Corp的股票代码是WGS。
GeneDx Holdings Corp股票的52周最高点是多少?
GeneDx Holdings Corp股票的52周最高点是170.87。
GeneDx Holdings Corp股票的52周最低点是多少?
GeneDx Holdings Corp股票的52周最低点是32.21。
GeneDx Holdings Corp的市值是多少?
GeneDx Holdings Corp的市值是1.93B。
现在GeneDx Holdings Corp(WGS)的股票是买入、持有还是卖出?
根据分析师评级,GeneDx Holdings Corp(WGS)的总体评级为买入,目标价格为92.89。
GeneDx Holdings Corp(WGS)股票的每股收益(EPS TTM)是多少
GeneDx Holdings Corp(WGS)股票的每股收益(EPS TTM)是-0.73。